PSTX insider transaction filings
Poseida Therapeutics, Inc. — 12 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-01-10. Screen PSTX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-01-10 | 4 | Malin Life Sciences Holdings Ltd — 10% owner | Code (U): 11,835,673 | EDGAR |
| 2025-01-08 | 4 | Amado Rafael — Director | Code (U): 58,950 · Disposition to issuer (D): 55,200 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Corning Luke — Director | Code (U): 58,950 · Disposition to issuer (D): 45,833 (derivative) @ $0 · Disposition to issuer (D): 28,500 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Mylet Johanna — Chief Financial Officer | Code (U): 254,852 · Disposition to issuer (D): 4,117 (derivative) @ $0 · Disposition to issuer (D): 80,192 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 82,000 (derivative) @ $0 · Disposition to issuer (D): 65,000 (derivative) @ $0 · +3 more | EDGAR |
| 2025-01-08 | 4 | Rizvi Syed Ali-aamir — Chief Medical Officer | Code (U): 185,000 · Disposition to issuer (D): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Yarema Kristin — President and CEO | Code (U): 615,836 · Disposition to issuer (D): 498,325 (derivative) @ $0 · Disposition to issuer (D): 345,200 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | BAUM CHARLES M — Director | Code (U): 78,600 · Disposition to issuer (D): 57,000 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Schmid John P. — Director | Code (U): 58,950 · Disposition to issuer (D): 32,076 (derivative) @ $0 · Disposition to issuer (D): 16,038 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 25,833 (derivative) @ $0 · +3 more | EDGAR |
| 2025-01-08 | 4 | Collins Cynthia — Director | Code (U): 58,950 · Disposition to issuer (D): 87,440 (derivative) @ $0 · Disposition to issuer (D): 28,500 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | LEONHARDT HARRY J — GC & Chief Compliance Officer | Code (U): 223,640 · Disposition to issuer (D): 160,385 (derivative) @ $0 · Disposition to issuer (D): 137,000 (derivative) @ $0 · Disposition to issuer (D): 72,568 (derivative) @ $0 · Disposition to issuer (D): 125,283 (derivative) @ $0 · Disposition to issuer (D): 111,700 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Lloyd Marcea Bland — Director | Code (U): 68,950 · Disposition to issuer (D): 32,076 (derivative) @ $0 · Disposition to issuer (D): 16,038 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 25,833 (derivative) @ $0 · +3 more | EDGAR |
| 2025-01-08 | 4 | Gergen Mark J — President and CEO, Director | Code (U): 636,726 · Disposition to issuer (D): 240,721 (derivative) @ $0 · Disposition to issuer (D): 48,115 (derivative) @ $0 · Disposition to issuer (D): 75,000 (derivative) @ $0 · Disposition to issuer (D): 342,000 (derivative) @ $0 · Disposition to issuer (D): 518,500 (derivative) @ $0 · +2 more | EDGAR |
Recent 8-K events — Poseida Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-01-08 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PSTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →